"Neglected Tropical Diseases" (NTDs) are lesser-known diseases, existing in the poorest communities in the shadow of the high-profile and well-funded "Big Three" (HIV/AIDS, tuberculosis, and malaria). Blame for neglect is pointed towards a number of protagonists: pharmaceutical companies for not investing in diseases of the poor but also donor governments and NGOs for directing attention at high mortality diseases. Yet other sites of neglect tend to be ignored, such as global governance priorities. Exclusion of NTDs from the Millennium Development Goals (MDGs) in 2000 started the ball rolling for an advocacy campaign to raise these diseases up the global health agenda. The MDG omission was used as a frame by advocates to highlight neglect and led to subsequent inclusion in the Sustainable Development Goals (SDGs). The SDGs, set out in 2015, now specifically include NTDs alongside AIDs, tuberculosis, malaria, hepatitis, water-borne diseases, and other communicable diseases, in a goal to end epidemics by 2030. However, a reframing based on a concept of neglect was not sufficient to ensure a place on the top of global health priorities. The NTD problem also needed to be made measurable, with metrics to provide a rationale for intervention set in evidence-based logic and to track progress towards success in quantifiable terms.]
Internal only - booking not required.
Venue: Oxford Martin School, Seminar Room 2